The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVRH.L Regulatory News (EVRH)

  • There is currently no data for EVRH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants

25 Jan 2018 18:03

RNS Number : 9839C
EVR Holdings PLC
25 January 2018
 

 

 

 

25 January 2018

 

EVR Holdings plc

('EVR' or the 'Company')

 

Exercise of Warrants and Issue of Shares

 

EVR Holdings plc (AIM: EVRH), one of the leading creators of virtual reality content, announces that it has received notice of exercise of warrants over 37,083 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 1.4 pence per share. The gross proceeds of this exercise, amounts to £519.16.

 

Following the warrant exercise, the number of warrants outstanding is as follows:

 Number

Exercise Price

Expiry Date

14,932,042

1.4p

31 July 2018

51,294,234

1.1p

16 May 2019*

21,561,866

1.85p

16 October 2019

9,230,180

1.2p

31 July 2020

 

*32,305,630 of these warrants are held by the EVRH board of directors

 

The Company has made application for the 37,083 new Ordinary Shares, to be issued and allotted as a result of the warrant exercises set out above, be admitted to trading on AIM. Admission is expected to occur at 8.00 a.m. on 31 January 2018. The 37,083 new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

For the purpose of the Disclosure and Transparency Rules, following the admission of 37,083 new Ordinary Shares, the Company's total issued ordinary share capital will consist of 1,157,651,348 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

- Ends -

 

For further information:

EVR Holdings plc

Anthony Matchett, Chief Executive Officer

Tel: +44 (0)20 3289 7430

www.evrholdings.com

Zeus Capital Limited (Nominated Adviser and Broker)

Andrew Jones

Tel: +44 (0) 203 829 5000

www.zeuscapital.co.uk

 

 

Notes to Editors:

 

MelodyVR

MelodyVR is a wholly owned subsidiary of EVR Holdings plc ('EVR'), a company that is listed on the AIM market of the London Stock Exchange under the ticker EVRH.L. EVR, a creator of virtual reality content, joined AIM on 16 May 2016 following a reverse takeover of Armstrong Ventures plc. Further information can be viewed at www.evrholdings.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBRGDBCUDBGIU
Date   Source Headline
15th Nov 20194:41 pmRNSSecond Price Monitoring Extn
15th Nov 20194:35 pmRNSPrice Monitoring Extension
6th Nov 20191:30 pmRNSMelodyVR extends partnership with GMA
17th Oct 20197:00 amRNSMelodyVR launches exclusive 5G partnership with O2
16th Oct 20195:45 pmRNSOption, Warrant Exercise and Option Pool Creation
23rd Sep 20194:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20192:00 pmRNSPrice Monitoring Extension
23rd Sep 201911:05 amRNSSecond Price Monitoring Extn
23rd Sep 201911:00 amRNSPrice Monitoring Extension
20th Sep 201911:46 amRNSSecond Price Monitoring Extn
20th Sep 201911:45 amRNSPrice Monitoring Extension
19th Sep 20199:05 amRNSSecond Price Monitoring Extn
19th Sep 20199:00 amRNSPrice Monitoring Extension
19th Sep 20197:00 amRNSHalf-year Report
18th Sep 20194:41 pmRNSSecond Price Monitoring Extn
18th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20192:05 pmRNSSecond Price Monitoring Extn
17th Sep 20192:00 pmRNSPrice Monitoring Extension
6th Sep 20191:00 pmRNSHolding(s) in Company
6th Sep 20197:00 amRNSMelodyVR Successfully Completes GMA Broadcast
27th Aug 201912:00 pmRNSMelodyVR Partners with Good Morning America
20th Aug 201912:00 pmRNSMelodyVR launches on Oculus Quest
12th Aug 201910:49 amRNSExercise of Warrants and Issue of Shares
8th Aug 20197:00 amRNSMelodyVR signs licensing and publishing agreements
22nd Jul 20197:00 amRNSHolding(s) in Company
22nd Jul 20197:00 amRNSExercise of Warrants and Issue of Shares
19th Jul 20191:16 pmRNSResult of Annual General Meeting
9th Jul 201911:00 amRNSMelodyVR successfully broadcasts Wireless Festival
9th Jul 20197:00 amRNSAppointment of Nominated Adviser and Sole Broker
4th Jul 20192:05 pmRNSSecond Price Monitoring Extn
4th Jul 20192:00 pmRNSPrice Monitoring Extension
4th Jul 201912:00 pmRNSMelodyVR licenses content to Facebook
4th Jul 20199:35 amRNSMelodyVR launched in 4 additional new markets
1st Jul 201912:00 pmRNSMelodyVR launches iOS/Android app to the public
21st Jun 201912:00 pmRNSNotice of AGM
21st Jun 20197:00 amRNSSubscription of £5 million by John Gore
20th Jun 20197:00 amRNSMelodyVR partners with Wireless Festival
19th Jun 20197:00 amRNSMelodyVR launches iOS/Android Beta and VR Viewer
17th Jun 20195:00 pmRNSAnnual Report & Accounts
7th Jun 20194:40 pmRNSSecond Price Monitoring Extn
7th Jun 20194:35 pmRNSPrice Monitoring Extension
7th Jun 20191:39 pmRNSStrategic Partnership with John Gore Organization
3rd Jun 20199:05 amRNSSecond Price Monitoring Extn
3rd Jun 20199:00 amRNSPrice Monitoring Extension
9th May 20197:00 amRNSEVR Final Results Year ended 31 December 2018
13th Mar 20197:00 amRNSMelodyVR signs 4 music licensing agreements
27th Feb 20197:00 amRNSAppointment of Chief Commercial Officer
24th Jan 20197:00 amRNSAgreement with AWAL & Warner Music Group extension
23rd Jan 20194:30 pmRNSExercise of Warrants and Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.